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Despite tremendous advances in surgery, primary chemotherapy, and novel treatments for recur-
rent disease, the diagnosis of advanced epithelial ovarian cancer in 2016 remains ultimately fatal in 
the majority of cases. Additionally, both the disease and the associated adjuvant treatment are not 
without substantial effect on overall quality of life. The cancer causes symptoms, but the treatment 
can cause even more significant problems, including neuropathy, nausea, fatigue, anorexia, and 
pain, among others. As oncology providers, we have a natural tendency to focus on the cancer and 
response to treatment rather than on the suffering of our patients related to treatment. Our patients 
in turn are reluctant to report their symptoms for fear that we will stop or change their treatment. 
As a result, though the cancer may be temporarily beaten into submission by aggressive surgery and 
adjuvant therapy, the patient may be simultaneously suffering from treatment-related symptoms that 
in some cases are permanent.
The early integration of palliative care in the treatment of women with advanced epithelial ovarian 
cancer allows us to address this quandary and not only improve quality of life but in some cases also 
prolong life. In the most well known of the randomized studies in cancer patients, 151 patients with 
newly diagnosed metastatic non-small cell lung cancer were randomized to integration of outpatient 
palliative care from the time of cancer diagnosis versus usual oncologic care (1). The early palliative 
care integration group not only had significant improvements in quality of life and mood but also 
(unexpectedly) had a statistically significantly improved overall survival (11.6 versus 8.9 months, 
p = 0.02), despite less aggressive intervention at the end of life. The results of this study have been 
confirmed by other studies in oncology patients (2–8). Our own Society of Gynecologic Oncology 
has advocated for inclusion of palliative care in the care of women with gynecologic cancer in their 
Choosing Wisely campaign.
What exactly is palliative care and how is this care best provided? The World Health Organization 
(WHO) defines palliative care as “an approach that improves the quality of life of patients and their 
families facing the problems associated with life-threatening illness, through the prevention and 
relief of suffering by means of early identification and impeccable assessment and treatment of pain 
and other problems, physical, psychosocial and spiritual”.1 Said another way, the palliative care 
approach to the patient is a holistic one that encompasses all aspects of the person and her caregiv-
ers/family, including those that many oncologists are ill equipped to address. Palliative care services 
are divided into primary palliative care and specialty primary care services. Most oncologists are 
trained to provide and feel comfortable providing primary palliative care for the patients; in the 
case of gynecologic oncologists, these services include basic symptom management and aligning 
treatment choices with patient goals. By contrast, specialty palliative care is provided by a team 
of providers, including a palliative care trained physician, nurse or advanced practice provider, 
1 http://www.who.int/cancer/palliative/definition/en/ Accessed Jan 2016
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social worker, chaplain, pharmacists, nutritionists, rehabilita-
tion therapists, and direct care workers, among others. The 
specialty palliative care team aims to address all of the domains 
of palliative care, including not only the physical but also the 
emotional, spiritual, and social domains of care. A complete 
assessment of palliative care needs includes all of these domains 
and so requires a multidisciplinary approach to the patient and 
her family. Thus, the early integration of palliative care allows us 
as oncology providers to continue to care for our patients with 
ovarian cancer while also addressing their suffering and improv-
ing overall quality of life.
Why then have we not embraced the early integration of 
palliative care into the care of women with advanced ovarian 
cancer? The most important barrier to early integration is a lack 
of understanding about exactly what the term “palliative care” 
means (9). Both patients and providers mistakenly consider 
palliative care to be synonymous with end-of-life care and, thus, 
incompatible with anticancer therapy. Patients are concerned 
that the introduction of palliative care means that the oncologist 
is “giving up,” and data from providers have shown that many 
mistakenly consider palliative care to be synonymous with 
end-of-life care and, thus, incompatible with anticancer therapy 
(9, 10). The Institute of Medicine report “Dying in America” 
concluded that “one of the greatest remaining challenges is 
the need for better understanding of the role of palliative care 
among both the public and professionals across the continuum 
of care so that hospice and palliative care can achieve their full 
potential for patients and their families”.2 Said Misconceptions 
about the role of hospice and the hospice benefit are also 
prevalent, resulting in few patients with ovarian cancer taking 
advantage of the hospice benefit at the end of life and very late 
hospice referral (11).
There are other important barriers to the integration of pal-
liative care early in the course of a malignancy, such as advanced 
ovarian cancer. These include the lack of availability of outpatient 
specialty palliative care services, poor reimbursement for pallia-
tive services, and a perceived lack of training and exposure by 
oncologists in provision of basic palliative care services. While 
most NCI-designated cancer centers have access to outpatient 
specialty palliative care services, these services are much less 
common in the community setting (12). Reimbursement for 
palliative care services remains poor, contributing to the lack 
of availability. Until recently, providers were not reimbursed for 
2 https://iom.nationalacademies.org/~/media/Files/Report%20Files/2014/EOL/
Report%20Brief.pdf Accessed Jan 2016
discussing advance care planning with their patients, a discussion 
that when done well can take a lot of time from a busy oncology 
clinic. Finally, surveys of both medical and gynecologic oncology 
fellows suggest that the trainees feel ill prepared to provide pri-
mary palliative care, to have difficult conversations, and to discuss 
end-of-life planning with their patients (13, 14). There is clearly 
room for improving the palliative curriculum and exposure in 
gynecologic oncology fellowships.
How then can we accomplish the early integration of palliative 
care into the care of our patients with advanced epithelial ovar-
ian cancer? The first step should be improved and continuing 
education of both the public and health care providers regarding 
what services palliative care provides and regarding the value of 
these services. It may be as simple as re-naming palliative care 
to supportive care in some cases while we further the education 
effort to avoid the confusion of palliative care with end-of-life 
care (15, 16). Early referral should be prioritized in the setting of 
a disease like advanced ovarian cancer, as patients will gain the 
most benefit from this approach (17). We also need to focus on 
better education of our trainees regarding palliative care and end-
of-life care, and we need to lobby for appropriate reimbursement 
for these time-intensive services. Finally, palliative care services 
will help our patients but will also help us as oncology providers 
by their ability to “share the load” (9).
Our patients with advanced ovarian cancer deserve the best 
overall care we can provide to them and to their families and 
caregivers. This best care includes the most aggressive surgery 
required to achieve complete cyto-reduction, the most effec-
tive chemotherapy (with clinical trial options), and the most 
appropriate and modern management of the inevitable disease 
recurrence; critical skills that all gynecologic oncologists learn 
and then master during their careers. But we must also be 
mindful of the important contribution of the early integration 
of palliative care services to our patients’ overall well-being. 
While the oncologist holds the “keys to the chemo,” resulting 
in a patient less likely to vocalize debilitating symptoms or non-
medical concerns, the palliative care team is able to focus on 
other aspects of the patient and her family’s care. Our ultimate 
goal should not be only to improve overall survival, but also to 
improve overall survival in the context of improved quality of 
life in all domains.
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